We propose the keyhole may be a feature of both 1-and 2-ARs, but that subtle structural differences exist between the two, contributing to subtype-selectivity. This has consequences for the rational design of future generations of subtypeselective ligands for these therapeutically important targets.
Introduction
The now rapidly-increasing number of XRC structures of GPCRs is providing a wealth of data about the structural basis of the mechanism of action of these pharmaceutically very important molecules and how this is modulated by ligand binding. (Congreve, Langmead, Mason, & Marshall, 2011; Heifetz et al., 2015; Katritch, Cherezov, & Stevens, 2012; B. K. Kobilka, 2007; 2011; Parrill & Bautista, 2010; Tate, 2012; Topiol & Sabio, 2009; Venkatakrishnan et al., 2013) In the case of -ARs, we now have crystal structures available for the human 2-and turkey 1-ARs in complexes with a range of agonists, antagonists, inverse agonists (Table 1 ) and a series of ligand subfragments. In addition there are G-protein and nanobody-bound structures, as well as an oligomeric apo-receptor structure. (Bokoch et al., 2010; Cherezov et al., 2007; Christopher et al., 2013; Hanson et al., 2008; J. Huang, Chen, Zhang, & Huang, 2013; Miller-Gallacher et al., 2014; Moukhametzianov et al., 2011; Rasmussen et al., 2007; 2011a; 2011b; Ring et al., 2014; Rosenbaum et al., 2011; Wacker et al., 2010; Warne, Edwards, Leslie, & Tate, 2012; Warne et al., 2011; Weichert et al., 2014; Zou, Weis, & Kobilka, 2012) The holo/liganded structures reveal a consistent mode of interaction with the receptors whether the receptor is in its inactive (R) or active (R*) state ( Figure 1 ). The orthosteric binding pockets of β1-and β2-ARs are almost identical.
Of the amino acids that line the pocket the only difference evident is at position 7.35 (Ballesteros-Weinstein numbering (Ballesteros & Weinstein, 1995) (Baker, Proudman, Hawley, Fischer, & Hill, 2008; Dixon et al., 1987; Strader et al., 1988; Strosberg, 1993) , XRCs indicate that the essential ethanolamine core (coloured blue in Table 1 and Figure 1 ), present in all -AR ligands with the exception of dobutamine and its sub-fragments, makes saltbridge and hydrogen-bonded interactions with Asp 3.32 and Asn 7.39 respectively. (Cherezov et al., 2007; Christopher et al., 2013; Hanson et al., 2008; J. Huang et al., 2013; Miller-Gallacher et al., 2014; Moukhametzianov et al., 2011; Rasmussen et al., 2007; 2011a; 2011b; Ring et al., 2014; Rosenbaum et al., 2011; Wacker et al., 2010; Warne et al., 2008; 2011; 2012; Weichert et al., 2014; Zou et al., 2012) The ethanolamine nitrogen atom is protonated at physiological pH and the carbinol stereochemistry of the higher affinity isomer is as shown in Table 1 . An extensive hydrogen-bonding network exists between the core and several further important residues (represented in Figure 1 as yellow arrows indicating the direction of H-bond donation). Tyr 7.43 plays a role in stabilising Asp 3.32 through an interhelical (H7-H3) Hbond (shown as a purple arrow), and has potential to interact with the core ethanolamine. N-Substituents of the ethanolamine ('tail' groups) extend in the general direction of the entrance channel towards the extracellular surface, while moieties attached to the carbinol side of the core pharmacophore ('head' groups) occupy a large and rather hydrophobic pocket in which Phe 6.52 and Phe 5.32 are often involved in π-stacking interactions and Val 3.33 is known to be important. (Bokoch et al., 2010; Chelikani et al., 2007; Cherezov et al., 2007; Christopher et al., 2013; Hanson et al., 2008; J. Huang et al., 2013; B. K. Kobilka, 2011; Lebon, Warne, & Tate, 2012; Moukhametzianov et al., 2011; Rasmussen et al., 2007; 2011a; 2011b; Rosenbaum et al., 2011; Wacker et al., 2010; Warne et al., 2008; 2011; 2012; Zou et al., 2012) The head group (coloured red in Tables 1 and 2 and Figure 1 ) largely determines whether the ligand is an agonist or antagonist (for the conventional G-protein signalling pathway). Biogenic amines such as adrenaline possess a catechol head group (1,2-dihydroxyphen-4-yl) attached directly to the core ethanolamine, which forms H-bonds with Ser 5.43 and Ser 5.46 on H5, respectively. (Rasmussen et al., 2011a; 2011b; Ring et al., 2013; Rosenbaum et al 2011; Warne et al., 2011; Weichert et al., 2014 to fully facilitate movement of H5; resulting in an antagonist, inverse agonist, or partial agonist ligand. (Bokoch et al., 2010; Cherezov et al., 2007; Christopher et al., 2013; Hanson et al., 2008; J. Huang et al., 2013; B. K. Kobilka, 2011; Lebon et al., 2012; Moukhametzianov et al., 2011; Rasmussen et al., 2007; Wacker et al., 2010; Warne et al., 2008; 2011; 2012; Zou et al., 2012) The R groups attached to the head group (Figure 1 ) represent the potential for structural diversity; heteroaromatic ring systems are common (see Table 1 ). The green line indicates conserved π-π stacking between Phe 6.52 and the common aromatic part of the head group, although if the ring system is larger, Phe 5.32 located on extracellular loop 2 (ECL2) can also contribute to π-π stacking (represented as dashed green line). Dashed yellow arrows indicate the general locations of previously observed ligand-dependent H-bonding between the β-ARs and antagonists (see references in Table 1 for details).
The carbazole NH present in carazolol (1) and the indolic NH moieties of cyanopindolol Table 1 ). Examples of the latter have been associated with biased receptor signalling (signalling mediated through pathways others than the G-proteins) (Liu, Horst, Katritch, Stevens, & Wuthrich, 2012; Warne et al., 2012) and subtype selectivity as longer tail groups have the potential to make interactions with the less conserved residues at the pocket entrance and extracellular surface of the receptor. (B. K. Kobilka, 2011) (Cherezov et al., 2007) 3.40 3.00 (Mistry et al., 2013) ; these are shown in Table 2 . One particular feature of many of these ligands is their increased selectivity, compared to less extensive ligands, for the 1-AR over the 2-AR ( Table 2 ). As part of our studies into the design and development of subtype-selective ligands, we attempted to dock these molecules to the known -AR XRC structures, and homology models of the human 1-and 2-AR that we have built from them. In all cases, using conventional docking methods (Glide), we found it almost impossible to generate poses for these ligands that resembled the canonical one, due to the inability of the extended ligand head groups to fit within the confines of the conventional binding pocket. Many of the poses generated failed to show convincing interactions for the ethanolamine core and failed to explain other aspects of known SARs. On this basis we concluded that it was worth investigating an alternative hypothesis for the activity of such ligands -not that they adopted an alternative pose in the -AR ligand binding site, but that this site in fact has as-yet unrecognised structural plasticity and can distort to accommodate the ligands whilst allowing them to maintain an otherwise conventional pose.
We envisaged that our Active Site Pressurization (ASP) method (Withers, Mazanetz, Wang, Fischer, & Laughton, 2008) would be ideal for this investigation. ASP simulates the process of injecting particles into a protein cavity rather like injecting a resin into a mould. The injection process takes place under pressure, so once the empty volume is filled, further expansion can take place in the most energetically favourable directions. The method does not involve making any prior decisions as to what the modes of deformation might be, nor does it require one to make any assumptions as to the size or shape of the molecule that will fit into the volume. Here we present the results of that study.
Remarkably, our findings suggest that the hydrophobic pocket in both the 1-and 2-AR contains a weak point in its wall between H4 and H5, such that ASP leads to the creation of a fissure in the pocket that leads out to the intra-membrane space. This fissure, which we term the 'keyhole', has exactly the position, dimensions, and chemical characteristics to permit ligands with extended head groups to bind to the receptors in the canonical orientation. Indeed, several of the -AR XRC structures corroborate our ASP findings. Though not specifically mentioned by the authors of the publications, 11 of the 16 1-AR structures and 1 of the 16 2-AR structures do in fact exhibit a keyhole, as a result of minor side-chain and backbone adjustments which to a large extent are as predicted by our ASP studies.
One of the few residues within 5 Å of the conventional binding pocket that is not conserved between the 1-and 2-AR is located at position 4.56 (Val 189 and Thr 164 in 1-and 2-AR respectively) and is one of five main residues which line the keyhole; it also happens to be the site of the naturally occurring 2-AR Thr 164 Ile polymorphism. (Green, Cole, Jacinto, Innis, & Liggett, 1993) This mutation results in reduced agonist affinity and slightly lower receptor basal activity. (Green et al., 1993; Green, Rathz, Schuster, & Liggett, 2001 ) Our findings suggest that this residue may well play an important role in ligand selectivity.
Methods

Homology modelling
Homology models were built using Prime (Green et al., 1993; 2001; Suite 2012 : Prime, version 3.1, Schrödinger LLC New York, NY, 2012 and refined using Maestro(Suite 2012: Maestro, version 9.3, Schrödinger, LLC, New York, NY, 2012) and the Prime loop refinement module (Jacobson, Friesner, Xiang, & Honig, 2002; Jacobson, Pincus, & Rapp, 2004) . The β2-T4L construct containing the ligand carazolol (1) (PDB code 2RH1) was reverse engineered to more accurately represent the human 2-AR wild-type sequence; chain B of the 2YCW XRC structure was used to model the human 1-AR sequence as it also contains carazolol (1), and despite being a thermostabilised avian construct (36-m23 (Jacobson et al., 2002; Moukhametzianov et al., 2011) ) with slightly different pharmacology to the human 1-AR, (Baker, Proudman, & Tate, 2011) it shares higher homology with human 1-AR than human 2-AR (2RH1) does. The wild-type human 1-AR and 2-AR sequences were obtained from NCBI(National Center for Biotechnology Information. Protein Database) and aligned to both crystal templates (2RH1 and 2YCW) using Prime. The alignment was checked using ClustalW (Larkin et al., 2007) and found to be in good agreement. The N-terminus of the 1-AR sequence was truncated by 49 residues, and 84 residues were removed from the C-terminus. Due to the limitations of loop modelling tools, no attempt was made to model the full length of the third intracellular loop, rather 45 residues were removed and the ends (Asp 259 and Arg 305 ) were joined to form a pseudo-loop. For 2-AR the Asn 187 Glu mutation in ECL2, which had been employed to eliminate a glycosylation site in the 2-T4L crystal construct, was reversed, the T4-lysozyme was removed and the third intracellular loop was replaced. This loop, despite being long, is still considerably shorter than that of the 1-AR isoform, and was successfully modelled using Prime's ultra-extended loop refinement tool with the addition of an Atom Specification Language (ASL) placed implicit membrane to exclude predictions that were not outside the membrane region. Unresolved N-and C-terminal regions were omitted as with the 1-AR model, resulting in a 2-AR model that spanned from Thr 25 to Cys 393 (inclusive). The template ligand carazolol (1) was preserved in both models but no water molecules or other heteroatoms were retained or added.
Active Site Pressurization
ASP was performed using the approach described by Withers et al., (Withers et al., 2008) re-implemented in code written in the modelling language NAB. (Macke & Case, 2009 ) Grids for the insertion of the Lennard-Jones (LJ) particles were built, with a 1.1 Å spacing, to encompass the region occupied by the carbazole group present in carazolol (1), plus a 7.0 Å margin along all axes beyond it. The starting seed particle from which the LJ cast grew outwards was chosen to correspond to the ether oxygen atom of carazolol (1) before the ligand was removed. The Amber ff99SB force field (Hornak et al., 2006) was used to parameterise the protein; default protonation states were used:
though there are suggestions that certain residues may exist at non-standard states, (Fahmy et al., 1993; Cherezov et al., 2007; Vanni, Neri, Tavernelli, & Rothlisberger, 2009; 2011 ) the ASP method is not expected to be sensitive to this as the residues in question (Asp encompassing the residues where movement involved in the formation of the fissure had previously been observed. The seed particle for this focused ASP grid corresponded with carazolol's (1) carbazole nitrogen atom. All other parameters were the same as in previous ASP runs (four replicates per system).
Docking
Docking was carried out using Glide. (Friesner et al., 2004; Suite 2012 : Glide, version 5.8, Schrödinger, LLC, New York, NY, 2012 Structures of all ligands in Table 1 and   Table 2 were drawn in Maestro's 2D sketcher and prepared with LigPrep(Suite 2012:
LigPrep, version 2.5, Schrödinger, LLC, New York, NY, 2012) to produce the Senantiomer carbinol group, and protonated nitrogen within the core ethanolamine (the additional chiral centre present in ICI-118,551 (7) was generated as both S and R).
Crystal structures were imported and prepared minimally (processed, water removed, not refined) with Maestro's protein preparation wizard. Using Glide, grids were produced based on the centre of carazolol (1) -this differed slightly depending on the crystal/model template; the relevant carazolol (1) molecule was used to select the centre for each grid. The grids each had a 10 Å 3 inner box based around the carazolol (1) centre, with an outer box of 38 Å 3 . Docking of all previously crystallised antagonist ligands (Table 1 ) to our models was first performed with no constraints and in several cases yielded poor results with few poses reflecting crystallographic ligand placement.
Subsequently, a core constraint was defined which required that ligands dock within 2.0 Å of the ethanolamine heavy atoms of each model's cognate carazolol (1) molecule.
This constraint was successful in producing poses highly similar to crystallographic data for each ligand and was implemented for all future docking. Extended Sampling was turned on, for each ligand 50 poses were minimised post-docking and a maximum 20 poses output. Default settings were used unless otherwise stated.
Molecular Dynamics
Selected ligand poses were refined using MD methods with AMBER 11. Pearlman et al., 1995) For this work all the ligands in Table 2 
Results
Homology models
Homology models were checked using PROCHECK (Laskowski, MacArthur, Moss, & Thornton, 1993) and Molprobity. (Davis et al., 2007) All models showed few outliers in Ramachandran plots (Supplementary Information Table S1 ); all of these outliers were found to be in intra-or extra-cellular loop regions far from the binding site. This finding is consistent with the template crystal structures, which also showed outliers, especially in the third intracellular loop. Due to the extremely high level of conservation between template binding sites (and subsequently models) we believe the models to be accurate enough for prediction of antagonist binding modes.
Initial docking attempts
When core constraints were used, we were able successfully to re-dock, using Glide, carazolol (1) and all other (Table 1) cognate ligands trialled to the 2RH1 and 2YCW
crystal structures, as well as the homology models of both the 1-and 2-AR ( Figure   2a ). H-bonding criteria were defined as a maximum H-X distance of 2.5 Å, a minimum donor angle of 90 ° and a minimum acceptor angle of 60 °. All top poses showed four H-bonds between the core ethanolamine and the conserved Asp 3.32 and Asn 7.39 residues.
The top scoring pose for each ligand was in most cases nearest to the crystallographic pose, as defined by manual superimposition of previously aligned XRCs (See Figure 2a and Supplementary Information Table S2 for GlideScores). H-bonding to S 228, 5.42 is not shown in the β1-AR model in Figure 2a (due to slightly unfavourable geometry, although proximity is good), but was seen in the β2-AR model, as with the XRC structures.
However, when the same protocol was used for extended head group ligands (Table 2) , we were unable to generate convincing poses consistently. In some cases the requirement that the core constraint be satisfied resulted in no docking poses at all being returned; when poses were produced they commonly exhibited fewer H-bonds between the ligand core ethanolamine and the Asp 3.32 and Asn 7.39 residues, and adopted either what we term 'U-shaped' or 'reversed' poses (See Supplementary Information Table S3 for GlideScores). U-shaped poses (Figure 2b ) are defined as a potential binding mode in an XRC or XRC-based model in which both the head and tail ends of the ligand are positioned towards the binding cavity entrance and extracellular surface of the -AR, often in solvent-accessible regions and not fully utilising the deeper, hydrophobic part of the binding cavity, which the head groups of all ligands in Table 1 occupy. Reversed poses (see Supplementary Information Figure S1 ) are defined as those in which the tail group is orientated towards the serine residues on H5, and the head group occupies the pocket entrance.
U-shaped poses were produced for all extended ligands except CGP20712A (14) in the 2-AR model, but in the 1-AR model U-shaped poses were only obtained for LK Figure S1 ).
To explore the possibility that these extended ligands actually adopt a significantly different, but consistent binding pose compared to the established ligands, the docking procedure was repeated without the core constraints. The result was that the extended (Table 2) ligands rarely made contacts with the conventional binding site but instead showed interactions with residues at the edge of the pocket and extracellular surface, with major inconsistencies between poses adopted by structurally closely related ligands (such as the reversed pose seen for ligand 15 but not for LK 204-545 (16)). The general absence of contacts deemed vital by SAR, mutation studies, and current structural knowledge from crystallography, suggested these non-core-constraint poses were unlikely to be valid.
Active Site Pressurization
ASP was applied to the homology models of both the 1-and 2-AR. In the first instance simulations were repeated ten times to assess the significance and reproducibility of structural perturbations that were observed. In the majority of cases, 
Docking studies after ASP
Glide was used to re-dock the extended ligands in Table 2 : acebutolol (10), betaxolol (11), esmolol (12), bisoprolol (13), CGP20712A (14), (15) and LK 204-545 (16), to the 1-and 2-AR models featuring the keyhole. For consistency with the earlier studies, these docking runs used the same restraints on core interactions (see Methods Section).
Although not always a high-scoring pose (see Supplementary Information Table S6 for GlideScores), in several cases a model was obtained in which simultaneously the extended head group moiety was located in the keyhole region, whilst the ethanolamine core was involved in the canonical interactions with Asp 3.32 and Asn 7.39 (Figures 4 and   5 ).
Ligands LK 204-545 (16) and (15) differ only in the presence of a cyano substituent on the aromatic ring in the former, yet the result of this addition is a significant increase in 1-AR binding affinity (-log Kd increased from -7.59 to -8.38, see Table 2 ). The docked poses for these ligands provide a plausible explanation for this ( Figure 5 ). We see that the cyano group is placed in close proximity to Asn 6.55 and the possibility of a favourable hydrogen bonding interaction between these two would be enhanced even further if the asparagine were to adopt one of the alternative rotamers that have been observed experimentally in 1-AR crystal structures. (Laskowski et al., 1993; Warne et al., 2011; 2012) 
Evaluation of U-shaped versus keyhole poses by molecular dynamics.
To explore further the relative merits of the U-shaped versus keyhole pose options, selected models for all ligands in Table 2 in complex with both 1-AR and 2-AR receptors were refined using AMBER. As far as possible, all simulations began from poses generated from the docking procedures; where no suitable start-point was available, ligands were manually docked into the appropriate 1-or 2-model using data from cognate ligands in cognate protein models. The MD runs were stable and in all cases the ligand stayed within the pocket/keyhole while always retaining H-bonding contacts between the ligand core ethanolamine and the Asp 3.32 and Asn 7.39 clamp. See Supplementary Information Figure S2 for a summary of all -AR residues implicated in H-bonding interactions.
H-bonding interactions between the ligand head/tail groups and the -ARs observed during MD
a) The 1-AR models
In addition to interactions with the core ethanolamine moiety, interactions commonly maintained between the 1-AR models and ligands in U-shaped poses included Hbonding between polar atoms in head group extensions and Asn 6.55 (acebutolol (10), bisoprolol (13), betaxolol (11) and 15), Arg 7.27 (acebutolol (10) and esmolol (12)), and the backbone of Thr 5.34 (esmolol (12)), residues which were all seen to be involved in H- interacting with both of these simultaneously, due to its amide moiety (other ligands contain ether or ester moieties in the corresponding position).
b) The 2-AR models
In the 2-AR model the U-shaped poses showed head groups interacting with Thr .32 salt bridge, the latter of which spans the entrance to the binding cavity of the 2-AR, hindering unbinding and stabilising the inactive conformation of the 2-AR (Bokoch et al., 2010; Davis et al., 2007; González, PerezAcle, Pardo, & Deupi, 2011; Selvam, Wereszczynski, & Tikhonova, 2012 suggesting that very small variations in backbone conformation can result in maintenance of the core ethanolamine binding site (and allow the core to dock) whist significantly affecting ligand tail placement. Our data suggest that tail groups have more freedom of movement generally as they tend to be orientated towards the extracellular entrance to the binding pocket, and do not stay anchored to a particular contact but move between several HBA/HBDs. Tail groups clearly play an important role in selectivity, due to their ability to make interactions with non-conserved extracellular surface residues.
Energetic analysis of alternative binding models
Using data from the last 10 ns of the simulation of each protein-ligand complex, the Amber11 MM-GBSA method was used to estimate free energies of binding. The results are shown in Table 3 . The β1-AR model containing the U-shaped betaxolol (11) pose failed to give a realistic free energy measure due to an unreasonably high VdW term (clashes between the ligand and receptor). CGP20712A (14) is not included in the data set as no U-shaped poses could be generated for this ligand. While, experimentally, all these ligands are 1-AR-selective (Baker, 2005; Benfield & Sorkin, 1987; S. N. S. Louis, Nero, Iakovidis, Jackman, & Louis, 1999; Mistry et al., 2013) , the MM-GBSA free energies of binding are almost always more favourable for the 2-AR. Though this suggests the approach has neglected an isoform-specific energy term, it does not alter the key observation that the MM-GBSA scores clearly support the idea that the keyhole poses are more favourable energetically. In fact, the only case where a U-shaped pose scores more highly than a keyhole pose is in the case of the 1-AR model complexed with LK 204-545 (16), but the difference is not significant when the standard error of the mean is considered. The relative energetic cost of creating a keyhole in 1-AR versus 2-AR may also play a role in selectivity, but this cannot be reported quantitatively here as the bulk solvent terms that come with the use of implicit solvent (as was the case for all ASP and subsequent MD studies) results in an energetic analysis that contains insufficient detail; we do note though (see section 3 above) that keyhole formation using ASP appears easier to initiate from the closed state of the 1-AR than the 2-AR.
Discussion
The application of the ASP process to both crystal structures and homology models of Table S7 ).
We also know that there is a great deal of conformational flexibility possible in the area of the keyhole associated with receptor activation -2-AR structures show a 2.1 Å movement of the Cα of Ser 5.46 when agonist and antagonist structures are compared (a difference of ~1 Å in the 1-AR turkey structures (González et al., 2011; Warne et al., 2011) ). We also observe various rotamer states of Ser 5.46 depending on whether it can directly H-bond to the ligand occupying the binding site, so our hypothesis that a keyhole can form in this region seems plausible.
Intriguingly, the apo crystal structure shows H4/H5 crystal contacts that juxtapose the keyholes of each protein (see Figure 6 ). Thus our docking findings suggest a possible novel binding mode for bivalent ligands. Valant, Robert Lane, Sexton, & Christopoulos, 2012) The keyhole hypothesis does not provide a complete rationalisation of the 1-AR selectivity for all extended ligands, as both 1-and 2-AR subtypes appear capable of producing this feature. However there are subtle differences between subtypes in the geometry and chemical composition of the keyhole due to the non-conserved this region more similar to those in 1-AR . Intriguingly, a water molecule can be found in or near to the keyhole region of several of the current 1-AR XRC structures to date. (Christopher et al., 2013; Miller-Gallacher et al., 2014; Warne et al., 2012) How these findings can be used to rationalise -AR SAR remains to be fully explored. It is known that subtype selectivity involves a complex cross talk between features in both the head and tail moieties. It may be that slight differences in how the molecules occupy the pocket, enforced by the constraints of the narrow keyhole region, alter the effectiveness of interactions between the tail extensions and key functional groups in the receptors. The current understanding is that the mechanism by which ligands enter the -ARs is different between subytpes. This is likely the case, when they share such conserved binding pockets but show such diverse pharmacology for ligands such as those discussed in this paper. It may be that the method by which ligands enter the 1AR is conducive to the formation of the keyhole, allowing extended ligands to utilise this feature on docking, or as an allosteric site. This fits with the known pharmacology, as a change in the residue lining the keyhole at position 4.56 from Val to Thr would result in a more polar keyhole region which may be occluded by water, forcing the hydrophobic head group extensions to adopt Ushaped poses rather than occupy the keyhole. on the ligand co-crystallised. (Valant et al., 2012; Warne et al., 2011; 2012) Larger ligands, such as those studied here, can be expected to bring about more drastic adaptations in protein structure. An example can be seen when comparing the A2A structures crystallised with agonists adenosine (Lebon et al., 2011; Warne et al., 2011) and UK432097, 2012; Xu et al., 2011 ) the latter of which induced a 3.8 Å widening of the binding pocket mouth due to extracellular loop rearrangement. (Lebon et al., 2011; Tate, 2012) The ability of computational methods to predict such adaptions has obvious importance when crystal structures remain, at times, elusive, and additionally is a valuable resource when there is a wish to think "outside the box" of existing structural data for the design of novel ligands.
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